Personal profile
Biography
I am an associate professor in clinical trial methodology and statistics working within the Department of Data Science and Biostatistics of the Julius Center where I lead the Clinical Trial Methodology & Statistical Consultation team. My interests lie in innovative clinical trial methodology (both development and application) and adaptive methods, trials-within cohorts and trials in rare diseases in particular. I am the Trial Methodology Lead for U-TRIAL and workpackage leader for the Adaptive Trial Platform WP in the ONCODE-ACCELERATOR growthfund project. I am the chair of the UMC Utrecht's internal DSMB. I also act as a methodology assessor (seconded) for the Dutch Medicines Evaluation Board (College ter Beoordeling van Geneesmiddelen: CBG-MEB).
From July 2009 until April 2021 I worked at the Amsterdam UMC location VUmc as a researcher, a statistical consultant and methodology member of the hospital's institutional review board (METc).
I hold a PhD degree in Statistics from Eindhoven University of Technology (2007), a M.A. degree in Health Psychology from Tilburg University (2003) and a M.Sc. degree in Engineering Mathematics from Eindhoven University of Technology (2001). I have held postdoctoral research positions at the Southampton Statistical Sciences Research Institute S3RI (2007-2008) and TNO Quality of Life (2008-2009).
External positions
Lid commissiepoule ZONMW programma Goed Gebruik Geneesmiddelen - Commissielid voor ZONMW GGG programma in eerste instantie Grote Trials rondes - ZONMW
1 Oct 2025 → 31 Dec 3999
Member of review committees Development (since January 2022) and PIPELINE (since April 2024) - Reviewer of grant applications submitted to Dutch Cancer Society (KWF) - KWF
1 Jan 2022 → 31 Dec 3999
Expert statistical reviewer - Performing statistical reviews of manuscripts submitted to Diabetologia journal - Diabetologia
1 May 2021 → 31 Dec 3999
Methodology assessor - Assessing dossiers filed for marketing authorization application and providing scientific advice - Dutch Medicines Evaluation Board (CBG-MEB)
1 May 2021 → 31 Dec 3999
Keywords
- HA Statistics
- Clinical trials
- Adaptive methods
- Bayesian methods
Collaborations and top research areas from the last five years
-
Bayesian Adaptive Randomized Trial of Blended Cognitive Behavioral Therapy for Severe Fatigue in Stable Diffuse Glioma
Gorter, M., Röttgering, J. G., Belgers, V., Blom, M. E. C., Thomassen, B., De Witt Hamer, P. C., Niers, J. M., Kouwenhoven, M. C. M., Bienfait, H. P., Gathier, C. S., Compter, A., Geurts, M., Snijders, T. J., Van De Ven, P. M., Douw, L., Knoop, H. & Klein, M., Mar 2026, In: Neuro-oncology. 283, 3, p. 693-703 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
Ethics of Backfilling in Early-Phase Oncology Trials
Hollestelle, M. J., Kessels, R., van de Ven, P. M. & van der Graaf, R., 10 Mar 2026, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 44, 8, p. 626-629 4 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Haemorrhagic Safety Update of CLEAR-PATH: 30 Day and 12 Month Antiplatelet Therapy After Peripheral Angioplasty
Wegerif, E. C. J., Generaal, M. I., Vijn, L. J., van den Bor, R. M., van de Ven, P. M., Bots, M. L., de Borst, G. J. & Ünlü, Ç., 2026, In: EJVES Vascular Forum. 65, p. 32-39 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Downloads (Pure) -
Innovative Oncology Trial Designs: TIME TO ACT A review with recommendations of the Cancer Drug Development Forum
Giuliani, R., Kronidou-Horst, N., Yap, C., Mejia, A. S., Leyens, L., Framke, T., Sweeney, F., Collette, L., Giles, R., Bogaerts, J., van de Ven, P. & Symeonides, S. N., Mar 2026, In: Journal of Cancer Policy. 47, 100696.Research output: Contribution to journal › Review article › peer-review
-
Onderzoek naar afbouw van stemmingsstabilisatoren vraagt om een andere studieopzet
Dols, A., van der Meer, P. B., Regeer, E. J. & van de Ven, P., Feb 2026, In: Tijdschrift voor Psychiatrie. 68, 2, p. 62-63 2 p.Translated title of the contribution :Research into tapering off mood stabilizers requires a different trial design Research output: Contribution to journal › Article › Academic › peer-review